author-photo

Sonja Heidu

University of Tübingen

2

Papers

5

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups

2021 Vaccine
Show All
- Source
- Cite
- Save
Citations (1)
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (4)